Recherche - Université de Picardie Jules Verne Accéder directement au contenu

Filtrer vos résultats

15 Résultats
Auteur : personID (entier) : 763185

Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID

Constance Chapuis-Biron , Julien Kirchgesner , Benjamin Pariente , Yoram Bouhnik , Aurelien Amiot , et al.
The American Journal of Gastroenterology, 2020, 115 (11), pp.1812-1820. ⟨10.14309/ajg.0000000000000810⟩
Article dans une revue hal-02930004v1
Image document

Prevalence of anti-TNF contraindications in Crohn’s disease: A cross-sectional survey from the GETAID

Aurelien Amiot , Philippe Seksik , Jean-Marie Reimund , Maria Nachury , Romain Altwegg , et al.
Digestive and Liver Disease, 2022, 54 (10), pp.1350-1357. ⟨10.1016/j.dld.2022.04.011⟩
Article dans une revue hal-03690498v1

The presence of adherent-invasive Escherichia coli strains on the surgical specimen is a predictor of severe endoscopic postoperative recurrence in Crohn's disease

N. Barnich , Anthony Buisson , Claire Auzolle , M. Rodrigues , Carmen Stefanescu , et al.
12. Congress of ECCO, European Crohn's and Colitis Organisation, Feb 2017, Barcelone, Spain
Communication dans un congrès hal-03553323v1

Impact of the Ileal microbiota on surgical site infections in Crohn’s disease: a nationwide prospective cohort

Clément Julien , Emré Anakok , Xavier Treton , Maria Nachury , Stéphane Nancey , et al.
Journal of Crohn's and Colitis, 2022, 16 (8), pp.1211-1221. ⟨10.1093/ecco-jcc/jjac026⟩
Article dans une revue hal-03638385v1
Image document

Association Between Microscopic Lesions at Ileal Resection Margin and Recurrence After Surgery in Patients With Crohn’s Disease

Nassim Hammoudi , Dominique Cazals-Hatem , Claire Auzolle , Charlotte Gardair , Marjolaine Ngollo , et al.
Clinical Gastroenterology and Hepatology, 2019, ⟨10.1016/j.cgh.2019.04.045⟩
Article dans une revue hal-02193633v1

Real‐world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti‐ TNF agent

Anthony Buisson , Maria Nachury , Thomas Guilmoteau , Romain Altwegg , Xavier Treton , et al.
Alimentary Pharmacology & Therapeutics (Suppl), 2022, pp.1-13. ⟨10.1111/apt.17305⟩
Article dans une revue hal-03870253v1
Image document

Effectiveness and safety of ustekinumab intensification at 90 Mg every four weeks In Crohn's disease: a multicenter study

Mathurin Fumery , Laurent Peyrin-Biroulet , Stéphane Nancey , Romain Altwegg , Cyrielle Gilletta , et al.
Journal of Crohn's and Colitis, 2021, 15 (2), pp.222-227. ⟨10.1093/ecco-jcc/jjaa177⟩
Article dans une revue hal-02959922v1

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease

Parambir S. Dulai , Aurélien Amiot , Laurent Peyrin-Biroulet , Vipul Jairaith , Mélanie Serrero , et al.
Alimentary Pharmacology and Therapeutics, 2020, 51 (5), pp.553-564. ⟨10.1111/apt.15609⟩
Article dans une revue hal-03552288v1

Predictors of post-operative endoscopic recurrence in Crohn's disease: a prospective study of the REMIND group

Matthieu Allez , Carmen Stefanescu , Stéphane Nancey , Anthony Buisson , Pierre Desreumaux , et al.
10. Congress of ECCO, European Crohn's and Colitis Organisation, Feb 2015, Barcelone, Spain. ⟨10.1093/ecco-jcc/jju027.076⟩
Communication dans un congrès hal-03553417v1

Checking the absence of inflammatory activity with an objective marker, a key point to succeed the switch from intravenous to subcutaneous infliximab in inflammatory bowel disease

Anthony Buisson , Maria Nachury , Mathurin Fumery
Clinical Gastroenterology and Hepatology, 2022, ⟨10.1016/j.cgh.2022.11.006⟩
Article dans une revue hal-03870157v1

Postoperative complications after ileo-caecal resection for Crohn's Disease: a prospective multicentre study

Mathurin Fumery , Philippe Seksik , Mircea Chirica , Jean-Marc Gornet , Gilles Boschetti , et al.
10. Congress of ECCO, European Crohn's and Colitis Organisation, Feb 2015, Barcelone, Spain. pp.S239-s239, ⟨10.1093/ecco-jcc/jju027.440⟩
Communication dans un congrès hal-03553419v1

Long-term efficacy and safety of ustekinumab in refractory Crohn's disease patients: a multicenter retrospective experience

Pauline Wils , Yoram Bouhnik , Pierre Michetti , Bernard Flourie , Hédia Brixi , et al.
12. Congress of ECCO, European Crohn's and Colitis Organisation, Feb 2017, Barcelone, Spain
Communication dans un congrès hal-03553341v1

Impact of abdominal or pelvic radiotherapy on disease activity in inflammatory bowel disease: a multicentre cohort study from the GETAID

Doriane Broussard , Pauline Riviere , Joelle Bonnet , Ginette Fotsing , Aurelien Amiot , et al.
Alimentary Pharmacology and Therapeuthics, 2021, 53 (3), pp.400-409. ⟨10.1111/apt.16176⟩
Article dans une revue hal-03228852v1
Image document

Evolution of endoscopic lesions in steroid-refractory acute severe ulcerative colitis responding to infliximab or cyclosporine

David Laharie , Arnaud Bourreille , Julien Branche , Matthieu Allez , Yoram Bouhnik , et al.
Clinical Gastroenterology and Hepatology, 2021, 19 (6), pp.1180-1188.e4. ⟨10.1016/j.cgh.2020.08.001⟩
Article dans une revue hal-03551241v1

Postoperative complications after ileocecal resection in Crohn's disease: A prospective study from the REMIND group

Mathurin Fumery , Philippe Seksik , Claire Auzolle , Nicolas Munoz-Bongrand , Jean-Marc Gornet , et al.
The American Journal of Gastroenterology, 2017, 112 (2), pp.337-345. ⟨10.1038/ajg.2016.541⟩
Article dans une revue hal-01604351v1